StonvexLoading…
StonvexStonvexStonvexCore line items from KAYS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $22.56K | $17.15K | $7.05K | $7.13K |
Operating Income | $-637.13K | $-368.12K | $-309.54K | $-2.02M |
Net Income | $-12.70M | $-4.11M | $-1.64M | $-2.08M |
EPS (Diluted) | $-0.16 | $-0.10 | $-0.04 | $-0.07 |
Total Assets | $199.36K | $254.43K | $197.29K | $216.37K |
Total Liabilities | $2.92M | $21.54M | $18.99M | $17.34M |
Cash & Equivalents | $26.09K | $48.15K | $50.72K | $39.67K |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | $-857.96K |
Shares Outstanding | 686.43M | 41.56M | 41.56M | 41.56M |